| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M202327200 |
| P698 | PubMed publication ID | 11960990 |
| P50 | author | Christian Cambillau | Q5109395 |
| Silvia Spinelli | Q28037071 | ||
| Serge Muyldermans | Q39183359 | ||
| Lode Wyns | Q48739361 | ||
| P2093 | author name string | Francoise Payan | |
| Aline Desmyter | |||
| Marc Lauwereys | |||
| P2860 | cites work | Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination | Q26778405 |
| PROCHECK: a program to check the stereochemical quality of protein structures | Q26778411 | ||
| A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops | Q27617837 | ||
| Camelid heavy-chain variable domains provide efficient combining sites to haptens | Q27621499 | ||
| Canonical antigen-binding loop structures in immunoglobulins: more structures, more canonical classes? | Q27625032 | ||
| Antigen specificity and high affinity binding provided by one single loop of a camel single-domain antibody | Q27631669 | ||
| Lateral recognition of a dye hapten by a llama VHH domain | Q27633538 | ||
| The crystal structure of porcine pancreatic alpha-amylase in complex with the microbial inhibitor Tendamistat | Q27730434 | ||
| The active center of a mammalian alpha-amylase. Structure of the complex of a pancreatic alpha-amylase with a carbohydrate inhibitor refined to 2.2-A resolution | Q27731333 | ||
| The crystal structure of a llama heavy chain variable domain | Q27733333 | ||
| Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme | Q27733338 | ||
| Substrate mimicry in the active center of a mammalian alpha-amylase: structural analysis of an enzyme-inhibitor complex | Q27734356 | ||
| Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features | Q27860675 | ||
| NMRPipe: a multidimensional spectral processing system based on UNIX pipes | Q27860859 | ||
| The CCP4 suite: programs for protein crystallography | Q27861090 | ||
| The atomic structure of protein-protein recognition sites | Q27861113 | ||
| Standard conformations for the canonical structures of immunoglobulins | Q28254522 | ||
| Naturally occurring antibodies devoid of light chains | Q28269589 | ||
| AMoRe: an automated package for molecular replacement | Q29642803 | ||
| Loss of splice consensus signal is responsible for the removal of the entire C(H)1 domain of the functional camel IGG2A heavy-chain antibodies | Q30766668 | ||
| The structure of the llama heavy chain constant genes reveals a mechanism for heavy-chain antibody formation | Q30803385 | ||
| Anatomy of the antibody molecule | Q34060425 | ||
| Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains | Q34214306 | ||
| Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains | Q34662422 | ||
| Camel single-domain antibody inhibits enzyme by mimicking carbohydrate substrate | Q38333730 | ||
| Camel heavy-chain antibodies: diverse germline V(H)H and specific mechanisms enlarge the antigen-binding repertoire | Q40387210 | ||
| T-cell receptor structure and TCR complexes | Q41685092 | ||
| Potent enzyme inhibitors derived from dromedary heavy-chain antibodies | Q41782789 | ||
| Conformations of the third hypervariable region in the VH domain of immunoglobulins | Q47626454 | ||
| P433 | issue | 26 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 23645-50 | |
| P577 | publication date | 2002-06-28 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Three camelid VHH domains in complex with porcine pancreatic alpha-amylase. Inhibition and versatility of binding topology | |
| P478 | volume | 277 |
| Q33525766 | A V H H that neutralizes the zinc metalloproteinase activity of botulinum neurotoxin type A |
| Q34979957 | A general protocol for the generation of Nanobodies for structural biology |
| Q33768721 | A portable RNA sequence whose recognition by a synthetic antibody facilitates structural determination |
| Q46071912 | Allosteric inhibition of VIM metallo-β-lactamases by a camelid nanobody |
| Q34995448 | Analysis and modeling of the variable region of camelid single-domain antibodies |
| Q42231409 | Analysis of heavy-chain antibody responses and resistance to Parelaphostrongylus tenuis in experimentally infected alpacas |
| Q89148188 | Antigen recognition by single-domain antibodies: structural latitudes and constraints |
| Q41863074 | Assessing predictions of protein-protein interaction: the CAPRI experiment |
| Q39574481 | Assessing the performance of the MM/PBSA and MM/GBSA methods. 6. Capability to predict protein-protein binding free energies and re-rank binding poses generated by protein-protein docking |
| Q47613358 | Assessment of blind predictions of protein-protein interactions: current status of docking methods |
| Q27677883 | Atypical Antigen Recognition Mode of a Shark Immunoglobulin New Antigen Receptor (IgNAR) Variable Domain Characterized by Humanization and Structural Analysis |
| Q47135878 | Camelid Single-Domain Antibodies: Historical Perspective and Future Outlook |
| Q35683767 | Camelid heavy chain only antibody fragment domain against β-site of amyloid precursor protein cleaving enzyme 1 inhibits β-secretase activity in vitro and in vivo |
| Q47221693 | Camelid immunoglobulins and nanobody technology. |
| Q33412211 | Camelid nanobodies raised against an integral membrane enzyme, nitric oxide reductase |
| Q89868257 | Caplacizumab in adult patients with acquired thrombotic thrombocytopenic purpura |
| Q27649162 | Comprehensive analysis of the factors contributing to the stability and solubility of autonomous human VH domains |
| Q30788281 | Contributions of CDR3 to V H H domain stability and the design of monobody scaffolds for naive antibody libraries |
| Q34431890 | Contributions of conventional and heavy-chain IgG to immunity in fetal, neonatal, and adult alpacas |
| Q27653797 | Crystal Structure of the N-Terminal Domain of the Secretin GspD from ETEC Determined with the Assistance of a Nanobody |
| Q47919372 | Crystal structure of HEL4, a soluble, refoldable human V(H) single domain with a germ-line scaffold |
| Q36348115 | Data on enhanced expression and purification of camelid single domain antibodies from Escherichia coli classical inclusion bodies |
| Q51859820 | Development of an affinity evaluation and prediction system by using the shape complementarity characteristic between proteins. |
| Q28211838 | Domain antibodies: proteins for therapy |
| Q47743214 | Domain swapping of a llama VHH domain builds a crystal-wide beta-sheet structure |
| Q51710121 | Efficient preparation and site-directed immobilization of VHH antibodies by genetic fusion of poly(methylmethacrylate)-binding peptide (PMMA-Tag). |
| Q31007389 | Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm |
| Q33963905 | Emergence and evolution of functional heavy-chain antibodies in Camelidae |
| Q55554478 | Evolution of Therapeutic Antibodies, Influenza Virus Biology, Influenza, and Influenza Immunotherapy. |
| Q90733985 | Exploring protein-protein interactions using the site-identification by ligand competitive saturation methodology |
| Q30372369 | Fully Human VH Single Domains That Rival the Stability and Cleft Recognition of Camelid Antibodies |
| Q35165250 | Genome-wide studies of protein-protein interaction |
| Q33941028 | High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosis |
| Q33888941 | High affinity, developability and functional size: the holy grail of combinatorial antibody library generation. |
| Q46664729 | ICM-DISCO docking by global energy optimization with fully flexible side-chains |
| Q33234082 | Identification by phage display of single-domain antibody fragments specific for the ODD domain in hypoxia-inducible factor 1alpha |
| Q38020872 | Immunoglobulin domains in Escherichia coli and other enterobacteria: from pathogenesis to applications in antibody technologies |
| Q35438411 | Isolation and characterization of a proteinaceous α-amylase inhibitor AAI-CC5 from Streptomyces sp. CC5, and its gene cloning and expression |
| Q30160034 | Lactococcal bacteriophage p2 receptor-binding protein structure suggests a common ancestor gene with bacterial and mammalian viruses |
| Q27658661 | Modulation of protein properties in living cells using nanobodies |
| Q34574853 | Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies |
| Q46786131 | Molecular cloning and expression of an alpha-amylase inhibitor from rye with potential for controlling insect pests |
| Q31049237 | Molecular imprint of enzyme active site by camel nanobodies: rapid and efficient approach to produce abzymes with alliinase activity |
| Q35066154 | Monoclonal antibodies for the structural analysis of the Na+/H+ antiporter NhaA from Escherichia coli |
| Q27653312 | Nanobody-aided structure determination of the EpsI:EpsJ pseudopilin heterodimer from Vibrio vulnificus |
| Q37829737 | Nanobody; an old concept and new vehicle for immunotargeting |
| Q30374078 | Predicting a double mutant in the twilight zone of low homology modeling for the skeletal muscle voltage-gated sodium channel subunit beta-1 (Nav1.4 β1). |
| Q39949452 | Present and future challenges and limitations in protein-protein docking |
| Q33205524 | Prokaryotic expression of antibodies and affibodies. |
| Q28487707 | Protein-protein docking with F(2)Dock 2.0 and GB-rerank |
| Q43260012 | Receptor-binding protein of Lactococcus lactis phages: identification and characterization of the saccharide receptor-binding site |
| Q52282024 | Recognition of the intrinsically flexible addiction antidote MazE by a dromedary single domain antibody fragment. Structure, thermodynamics of binding, stability, and influence on interactions with DNA. |
| Q33379102 | Relevance of the diversity among members of the Trypanosoma cruzi trans-sialidase family analyzed with camelids single-domain antibodies |
| Q34057785 | Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge |
| Q90594656 | Structure and development of single domain antibodies as modules for therapeutics and diagnostics |
| Q90395153 | Structure and specificity of several triclocarban-binding single domain camelid antibody fragments |
| Q41891811 | Structure of a shark IgNAR antibody variable domain and modeling of an early-developmental isotype |
| Q27665314 | Structures of a key interaction protein from the Trypanosoma brucei editosome in complex with single domain antibodies |
| Q40988950 | The membrane bound bacterial lipocalin Blc is a functional dimer with binding preference for lysophospholipids |
| Q24800574 | The production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi |
| Q48222755 | Type VI secretion TssK baseplate protein exhibits structural similarity with phage receptor-binding proteins and evolved to bind the membrane complex |
| Q35575686 | VORFFIP-driven dock: V-D2OCK, a fast and accurate protein docking strategy |
| Q27677064 | Viral infection modulation and neutralization by camelid nanobodies |
Search more.